JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cochin, J.
Right arrow Articles by Seevers, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cochin, J.
Right arrow Articles by Seevers, M. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 101, Issue 2, 205-209, 1951
Copyright © 1951 by American Society for Pharmacology and Experimental Therapeutics


THE ABSORPTION, DISTRIBUTION AND URINARY EXCRETION OF MESCALINE IN THE DOG

J. Cochin 1, L. A. Woods 1, and M. H. Seevers 1

1 Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

1. The plasma levels of mescaline in dog plasma have been determined following intravenous, intramuscular, and oral administration of 20 mgm./kgm. of mescaline sulfate. The decay curves follow the characteristic slope usually related to differences in the route of administration. The intensity of the signs of the pharmacological action of mescaline parallels the plasma levels.

2. Renal elimination of unaltered mescaline in the dog accounts for 28 to 46 per cent of an administered dose, the larger portion of the eliminated fraction being excreted within four and one-half hours and the remainder within twenty-four hours. Only traces of 3,4,5-trimethoxyphenylacetic acid could be detected in the urine.

3. During the first four hours after intravenous administration the concentration of mescaline in the kidney, liver, or spleen is three to six fold higher than in plasma or brain.

Submitted on October 30, 1950







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1951 by the American Society for Pharmacology and Experimental Therapeutics.